The Bronchodilators market size is expected to reach $47.96 billion in 2030 at a CAGR of 6.3%, driven by increasing prevalence of chronic obstructive pulmonary disease.
Read More
The Bronchiolitis Obliterans Syndrome market size is expected to reach $2.43 billion in 2030 at a CAGR of 8.7%, driven by growing number of lung transplantations.
Read More
The Breast Milk Substitutes market size is expected to reach $26.14 billion in 2030 at a CAGR of 8.3%, driven by rising female workforce participation.
Read More
The Breast Cancer Monoclonal Antibodies market size is expected to reach $33.27 billion in 2030 at a CAGR of 9.2%, driven by rising prevalence of breast cancer globally.
Read More
The Breast Cancer Gene (BRCA) Mutations Treatment market size is expected to reach $7 billion in 2030 at a CAGR of 6.9%, driven by rising demand for targeted therapies.
Read More
The Breast Cancer Drugs market size is expected to reach $61.19 billion in 2030 at a CAGR of 7.8%, driven by increasing prevalence of breast cancer.
Read More
The Branded Generics market size is expected to reach $653.17 billion in 2030 at a CAGR of 10.7%, driven by increasing prevalence of chronic diseases.
Read More
The Brain Tumor Drugs market size is expected to reach $5.5 billion in 2030 at a CAGR of 6.6%, driven by rising number of patients undergoing chemotherapy.
Read More
The Brain Health Supplements market size is expected to reach $20.84 billion in 2030 at a CAGR of 12.1%, driven by increasing prevalence of brain diseases.
Read More
The Bradykinesia market size is expected to reach $6.38 billion in 2030 at a CAGR of 13.3%, driven by increasing prevalence of neurological disorders.
Read More